Diana Reyes writes about weight management and metabolic health with a practical, judgment-free approach. She follows the fast-moving world of GLP-1 medications and metabolic peptides closely, translating the research into clear guidance on sustainable fat loss and body recomposition.
Diana Reyes
There’s a conversation that happens constantly in peptide and GLP-1 communities, and it’s both understandable and frustrating: “I’ve ...
The GLP-1 market is about to get significantly more competitive, and the mechanism of that competition may redefine ...
We’ve known for a while that tirzepatide produces superior weight loss compared to other GLP-1 medications. The question ...
The debate between tirzepatide and semaglutide has dominated GLP-1 conversations for three years. Anecdotes, clinical trials, and forum ...
Latest News
